Earnings History Data for Supernus Pharmaceuticals, Inc. (SUPN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit hyperactivity disorder. Supernus Pharmaceuticals Inc. is based in Rockville, Maryland.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
27-02-2024	AH		SUPN	Supernus Pharmaceuticals, Inc.	1,590	0.02	0.41	0.43	Supernus Pharmaceuticals GAAP EPS of $0.02 beats by $0.04, revenue of $164.3M beats by $9.27M [2/27/2024 4:28 PM]	31.12	0.43 (1.41%)	28.23	-2.46 (-8.02%)	21.99 - 40.12	830,199	370,000	13,139
Supernus Pharmaceuticals GAAP EPS of $0.02 beats by $0.04, revenue of $164.3M beats by $9.27M [2/27/2024 4:28 PM]
08-11-2023	AH		SUPN	Supernus Pharmaceuticals, Inc.	1,310	-0.29	0.13	0.03	Supernus Pharmaceuticals GAAP EPS of -$0.29 in-line, revenue of $153.88M beats by $10.49M [11/8/2023 4:39 PM]	26.15	2.63 (11.18%)	24.75	1.23 (5.23%)	21.99 - 42.09	910,341	450,000	1,540
Supernus Pharmaceuticals GAAP EPS of -$0.29 in-line, revenue of $153.88M beats by $10.49M [11/8/2023 4:39 PM]
08-08-2023	AH		SUPN	Supernus Pharmaceuticals, Inc.	1,750	-0.02	0.23	0.14	Supernus Pharmaceuticals GAAP EPS of -$0.02 beats by $0.21, revenue of $135.6M misses by $8.06M [8/8/2023 4:33 PM]	30.31	-2.60 (-7.90%)	31.45	-1.46 (-4.44%)	29.06 - 42.09	1,275,832	390,000	6,138
Supernus Pharmaceuticals GAAP EPS of -$0.02 beats by $0.21, revenue of $135.6M misses by $8.06M [8/8/2023 4:33 PM]
09-05-2023	AH	4:05 PM ET (May 9)	SUPN	Supernus Pharmaceuticals, Inc.	2,000	0.29	0.12	0.43	Supernus Pharmaceuticals GAAP EPS of $0.29 beats by $0.55, revenue of $153.8M beats by $14.78M [5/9/2023 4:20 PM]	36.65	0.47 (1.30%)	36.18	0.0 (0.00%)	24.95 - 42.09	683,013	260,000	3,999
Supernus Pharmaceuticals GAAP EPS of $0.29 beats by $0.55, revenue of $153.8M beats by $14.78M [5/9/2023 4:20 PM]
28-02-2023	AH	4:05 PM ET (Feb 28)	SUPN	Supernus Pharmaceuticals, Inc.	2,090	0.43	0.73	0.04	Supernus Pharmaceuticals reports Q4 results, sees FY 2023 revenue in-line [2/28/2023 4:27 PM]	39.19	1.60 (4.26%)	37.59	0.0 (0.00%)	24.95 - 42.09	713,493	340,000	12,936
Supernus Pharmaceuticals reports Q4 results, sees FY 2023 revenue in-line [2/28/2023 4:27 PM]
08-11-2022	AH	4:00 PM ET (Nov 8)	SUPN	Supernus Pharmaceuticals, Inc.	1,840	0.03	0.31	0.40	Supernus Pharmaceuticals GAAP EPS of $0.03 misses by $0.33, revenue of $177.35M beats by $4.87M [11/8/2022 4:20 PM]	32.80	-1.90 (-5.48%)	34.70	0.0 (0.00%)	24.95 - 36.08	616,131	350,000	49,742
Supernus Pharmaceuticals GAAP EPS of $0.03 misses by $0.33, revenue of $177.35M beats by $4.87M [11/8/2022 4:20 PM] Supernus Announces Third Quarter 2022 Financial Results [Nov-08-22 04:05PM]
04-08-2022	AH	4:05 PM ET (Aug 4)	SUPN	Supernus Pharmaceuticals, Inc.	1,630	0.14	0.29	0.43	Supernus Pharmaceuticals GAAP EPS of $0.14 misses by $0.15, revenue of $170.05M beats by $5.82M [8/4/2022 4:08 PM]	32.16	-0.65 (-1.98%)	32.16	0.0 (0.00%)	23.15 - 34.50	640,765	410,000	4,310
Supernus Pharmaceuticals GAAP EPS of $0.14 misses by $0.15, revenue of $170.05M beats by $5.82M [8/4/2022 4:08 PM] Supernus Announces Second Quarter 2022 Financial Results [Aug-04-22 04:01PM]
09-05-2022	AH	4:10 PM ET (May 9)	SUPN	Supernus Pharmaceuticals, Inc.	1,500	0.43	0.26	0.11	Supernus Pharmaceuticals GAAP EPS of $0.43 misses by $0.02, revenue of $152.51M beats by $2.04M [5/9/2022 4:15 PM]	26.01	-0.36 (-1.35%)	26.37	0.0 (0.00%)	23.15 - 34.50	551,233	479,953	9,302
Supernus Pharmaceuticals GAAP EPS of $0.43 misses by $0.02, revenue of $152.51M beats by $2.04M [5/9/2022 4:15 PM] Supernus Announces First Quarter 2022 Financial Results [May-09-22 04:05PM]
13-04-2022	AH	4:00 PM ET (Apr 4)	SUPN	Supernus Pharmaceuticals	1,683	0.04	0.24	0.00	Supernus Pharmaceuticals GAAP EPS of $0.04 misses by $0.20, revenue of $159.05M in-line [4/13/2022 4:16 PM]	31.11	-1.52 (-4.66%)	31.75	-0.88 (-2.70%)	23.15 - 34.50	412,827	530,000	734
Supernus Pharmaceuticals GAAP EPS of $0.04 misses by $0.20, revenue of $159.05M in-line [4/13/2022 4:16 PM] Supernus Reports Final Audited Fourth Quarter and Full Year 2021 Financial Results [Apr-13-22 04:11PM]
28-02-2022	AH	4:00 PM ET (Feb 28)	SUPN	Supernus Pharmaceuticals, Inc.	1,710	N/A	0.21	0.57	Supernus Pharmaceuticals reports Q4 results [2/28/2022 4:17 PM]	29.68	-2.27 (-7.10%)	29.50	-2.45 (-7.67%)	23.15 - 34.50	2,015,700	590,000	5,358
Supernus Pharmaceuticals reports Q4 results [2/28/2022 4:17 PM] Supernus Announces Preliminary Fourth Quarter and Full Year 2021 Financial Results [Feb-28-22 04:05PM]
03-11-2021	AH	4:10 PM ET (Nov 3)	SUPN	Supernus Pharmaceuticals, Inc.	1,610	0.40	0.21	0.74	Supernus Pharmaceuticals EPS beats by $0.17, beats on revenue; updates full year guidance [11/3/2021 4:05 PM]	31.56	1.53 (5.09%)	31.56	0.0 (0.00%)	20.22 - 34.29	873,632	320,000	3,207
Supernus Pharmaceuticals EPS beats by $0.17, beats on revenue; updates full year guidance [11/3/2021 4:05 PM] Supernus up 10% following 2021 earnings guidance boost, Q3 beat [11/3/2021 6:01 PM] ADAMAS PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Adamas Pharmaceuticals, Inc. - ADMS [Nov-02-21 06:30PM] Supernus Announces Third Quarter 2021 Financial Results [Nov-03-21 04:01PM] Supernus Pharmaceuticals (SUPN) Q3 Earnings and Revenues Beat Estimates [Nov-03-21 05:55PM] Supernus Pharmaceuticals, inc (SUPN) Q3 2021 Earnings Call Transcript [Nov-04-21 12:01AM]
04-08-2021	AH	4:00 PM ET (Aug 4)	SUPN	Supernus Pharmaceuticals, Inc.	1,400	0.43	0.17	0.65	Supernus Pharmaceuticals EPS beats by $0.23, beats on revenue [8/4/2021 4:19 PM]	26.55	-0.63 (-2.32%)	26.83	-0.35 (-1.29%)	17.20 - 34.29	385,219	340,000	150
Supernus Pharmaceuticals EPS beats by $0.23, beats on revenue [8/4/2021 4:19 PM] Supernus Announces Second Quarter 2021 Financial Results [Aug-04-21 04:09PM] Supernus Pharmaceuticals (SUPN) Beats Q2 Earnings and Revenue Estimates [Aug-04-21 06:15PM] Supernus Pharmaceuticals, inc (SUPN) Q2 2021 Earnings Call Transcript [Aug-04-21 11:01PM]
05-05-2021	AH	4:00 PM ET (May 5)	SUPN	Supernus Pharmaceuticals, Inc.	1,610	0.11	0.26	0.40	Supernus Pharmaceuticals EPS misses by $0.11, beats on revenue; reaffirms guidance [5/5/2021 4:04 PM]	29.29	-1.20 (-3.94%)	29.29	0.0 (0.00%)	17.20 - 32.31	795,750	460,000	5,834
Supernus Announces Paragraph IV ANDA Filing for XADAGO® [May-04-21 08:49PM] Supernus Pharmaceuticals, Inc. to Host Earnings Call [May-05-21 02:45PM] Supernus Announces First Quarter 2021 Financial Results [May-05-21 04:01PM] Supernus Pharmaceuticals (SUPN) Q1 Earnings and Revenues Miss Estimates [May-05-21 06:45PM] Supernus Pharmaceuticals Inc (SUPN) Q1 2021 Earnings Call Transcript [May-05-21 10:01PM]
03-11-2020	AH	6:05 PM ET (Nov 3)	SUPN	Supernus Pharmaceuticals, Inc.	966.91	0.74	0.27	0.54	Supernus Pharmaceuticals EPS beats by $0.47, beats on revenue [11/3/2020 4:32 PM]	22.48	4.32 (23.83%)	21.35	3.20 (17.63%)	13.12 - 29.36	1,910,194	381,304	26,833

18-08-2020	AH	6:45 PM ET (Aug 18)	SUPN	Supernus Pharmaceuticals, Inc.	1,270	0.65	0.35	0.61	Supernus Pharmaceuticals EPS beats by $0.16, misses on revenue [8/18/2020 4:58 PM]	24.02	-1.03 (-4.11%)	25.10	0.05 (0.20%)	13.12 - 29.81	419,888	486,429	2,373

05-05-2020	AH	4:40 PM ET (May 5)	SUPN	Supernus Pharmaceuticals, Inc.	1,220	0.40	0.30	0.34	Supernus Pharmaceuticals EPS beats by $0.13, beats on revenue [5/5/2020 7:53 PM]	22.17	0.03 (0.14%)	0.0	0.0 (0.00%)	13.12 - 38.74	353,891	498,004	0